Government Funds Begin To Flow For More Research On Addiction

Federal agencies welcome ideas for developing new medications to curb, treat, or prevent a host of drug addictions. WASHINGTON--The federal government is strengthening its commitment to research on drug addiction. And that means a greater demand for scientists. "We are in desperate need of both Ph.D. and M.D. clinical researchers," says Marvin Snyder, director of the Division of Preclinical Research at the National Institute on Drug Abuse (NIDA). "And we have the money." NIDA wants to develo

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Federal agencies welcome ideas for developing new medications to curb, treat, or prevent a host of drug addictions.
WASHINGTON--The federal government is strengthening its commitment to research on drug addiction. And that means a greater demand for scientists.

"We are in desperate need of both Ph.D. and M.D. clinical researchers," says Marvin Snyder, director of the Division of Preclinical Research at the National Institute on Drug Abuse (NIDA). "And we have the money."

NIDA wants to develop drugs to treat a range of addictions in much the same way that methadone is used to treat heroin addicts. It's the research prong of the government's overall attack on the drug epidemic that so far has consisted mainly of more prisons, more police, and more aid to countries where some of the illegal drugs are grown.

Last year NIDA funded some $31 million in addiction research, $10 million of which came from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Susan Landers

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo